New Influx of Humira Biosimilars May Not Drive Immediate Change New Influx of Humira Biosimilars May Not Drive Immediate Change

As many as 8 to 10 adalimumab biosimilars are anticipated to come on the market this year, giving mainstay drug Humira some vigorous competition.MDedge News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Gastroenterology News Source Type: news